NewsBenzingaSeres Therapeutics、第3四半期EPSは(1.63ドル)で予想(1.00ドル)を下回る、売上高は59万3,000ドルで予想635万ドルを下回る Seres Therapeutics、第3四半期EPSは(1.63ドル)で予想(1.00ドル)を下回る、売上高は59万3,000ドルで予想635万ドルを下回る Benzinga 2026.11.04 12:13 (GMT+0) Open on Benzinga Other news Keybanc Reiterates Sector Weight on NVIDIAto Sector Weight Top 3 Tech Stocks That May Fall Off A Cliff This Month Truist Securities Maintains Hold on BILL Holdings, Raises Price Target to $66 Nvidia’s China Exit Could Trigger a Bull-Bear Showdown: 6 Leveraged ETFs to Watch Wednesday OTraces Selects Labcorp To Perform Reference Laboratory Testing For Florida Department Of Health–Funded Clinical Trial Evaluating OTraces Blood-Based Prostate Cancer Diagnostic Platform Quanterix Affirms FY2026 Sales Guidance of $142.000M-$146.000M vs $143.357M Est
OTraces Selects Labcorp To Perform Reference Laboratory Testing For Florida Department Of Health–Funded Clinical Trial Evaluating OTraces Blood-Based Prostate Cancer Diagnostic Platform